← Back to Clinical Trials
Recruiting NCT06587204
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
Trial Parameters
Condition Heart Diseases
Sponsor University of Miami
Study Type INTERVENTIONAL
Phase N/A
Enrollment 125
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-09-15
Completion 2026-12-31
Interventions
Control GroupDecentralized GroupDigital Literacy Navigation Group
Brief Summary
The objective of the UDECIDE study is to demonstrate adherence to decentralized clinical trials among underrepresented groups with cardiometabolic conditions .
Eligibility Criteria
Inclusion Criteria: * History of pre-diabetes/diabetes and/or pre-hypertension/hypertension * History of Cardiometabolic risk factors including the following: hypertension, Coronary Artery Disease (CAD), heart attack, heart failure, stroke, atherosclerosis, arrhythmias, Peripheral Artery Disease (PAD), type 2 diabetes, metabolic syndrome, obesity, dyslipidemia, insulin resistance, or elevated cholesterol. * Identify as Black or non-White Hispanic * Own a smart phone Exclusion Criteria: * Does not meet inclusion criteria